Research Triangle AI raises $28M Series B to bring its drug discovery AI platform from lab partnerships to pharmaceutical commercialization.
Research Triangle AI, a Durham-based AI company focused on computational drug discovery, announced a $28 million Series B funding round led by Sequoia Capital.
Research Triangle AI